While payer deals are becoming the name of the game in the newly competitive hepatitis C field, AbbVie Inc. Chief Financial Officer William Chase stressed during the firm’s breakout session at the J.P. Morgan Healthcare conference Jan. 14 that AbbVie is in a position to compete in the open market as well as with exclusive payer arrangements.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?